QQ客服 官方微博 反馈留言

浏览/检索结果: 共22条，第1-10条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion 期刊论文 EUROPEAN UROLOGY, 2019, 卷号: 75, 期号: 5 作者:  Fu, Qiang;  Xu, Le;  Wang, Yiwei;  Jiang, Qi;  Liu, Zheng 收藏  |  浏览/下载：56/0  |  提交时间：2019/12/05 Clear cell renal cell carcinoma  Glutamine metabolism  Interleukin-23  Tumor-associated macrophages  Regulatory T cells  Immunotherapy   Identification of High Serum Apolipoprotein A1 as a Favorable Prognostic Indicator in Patients with Multiple Myeloma 期刊论文 JOURNAL OF CANCER, 2019, 卷号: 10, 期号: 20 作者:  Liang, Lifan;  Li, Jing;  Fu, Hangcheng;  Liu, Xinyang;  Liu, Peng 收藏  |  浏览/下载：25/0  |  提交时间：2019/12/05 multiple myeloma  lipid profile  apolipoprotein A1  prognosis  prognostic model   Prognostic and Predictive Value of O-6-methylguanine Methyltransferase for Chemotherapy in Patients with Muscle-Invasive Bladder Cancer 期刊论文 ANNALS OF SURGICAL ONCOLOGY, 2018, 卷号: 25, 期号: 1 作者:  Fu, Hangcheng;  Zhang, Junyu;  Zhu, Yu;  Wang, Yiwei;  Fu, Qiang 收藏  |  浏览/下载：5/0  |  提交时间：2019/12/05 B4GALT1 expression predicts prognosis and adjuvant chemotherapy benefits in muscle-invasive bladder cancer patients 期刊论文 BMC CANCER, 2018, 卷号: 18 作者:  Xie, Huyang;  Zhu, Yu;  Zhang, Junyu;  Liu, Zheng;  Fu, Hangcheng 收藏  |  浏览/下载：19/0  |  提交时间：2019/12/05 Adjuvant chemotherapy  B4GALT1  Muscle-invasive bladder cancer  Overall survival  Prognosis   Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer 期刊论文 ONCOIMMUNOLOGY, 2018, 卷号: 7, 期号: 9 作者:  Liu, Zheng;  Zhu, Yu;  Xu, Le;  Zhang, Junyu;  Xie, Huyang 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 adjuvant chemotherapy  bladder cancer  mast cells  overall survival  prognosis  recurrence-free survival   Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer 期刊论文 CLINICAL CANCER RESEARCH, 2018, 卷号: 24, 期号: 13 作者:  Fu, Hangcheng;  Zhu, Yu;  Wang, Yiwei;  Liu, Zheng;  Zhang, Junyu 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/05 Galectin-9 as a prognostic and predictive biomarker in bladder urothelial carcinoma 期刊论文 UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS, 2017, 卷号: 35, 期号: 6 作者:  Liu, Yidong;  Liu, Zheng;  Fu, Qiang;  Wang, Zewei;  Fu, Hangcheng 收藏  |  浏览/下载：7/0  |  提交时间：2019/12/05 Bladder cancer  Galectin-9  Prognosis  Predictive biomarker  Adjuvant chemotherapy   How do organ-specific metastases affect prognosis and surgical treatment for patients with metastatic upper tract urothelial carcinoma: first evidence from population based data 期刊论文 CLINICAL & EXPERIMENTAL METASTASIS, 2017, 卷号: 34, 期号: 8 作者:  Dong, Fan;  Fu, Hangcheng;  Shi, Xiao;  Shen, Yifan;  Xu, Tianyuan 收藏  |  浏览/下载：8/0  |  提交时间：2019/12/05 Metastatic upper tract urothelial carcinoma  Metastatic organ  Surgical resection of the primary tumor  Overall survival  Cancer specific survival   Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell Carcinoma 期刊论文 ANNALS OF SURGICAL ONCOLOGY, 2017, 卷号: 24, 期号: 5 作者:  Fu, Hangcheng;  Zhu, Yu;  Wang, Yiwei;  Liu, Zheng;  Zhang, Junyu 收藏  |  浏览/下载：4/0  |  提交时间：2019/12/05 High CXC chemokine receptor 1 level represents an independent negative prognosticator in non-metastatic clear-cell renal cell carcinoma patients 期刊论文 ONCOIMMUNOLOGY, 2017, 卷号: 6, 期号: 11 作者:  Zhu, Yu;  Liu, Zheng;  Wang, Yiwei;  Fu, Hangcheng;  Wang, Zewei 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/05 clear-cell renal cell carcinoma  CXC chemokine receptor 1  overall survival  prognostic biomarker  recurrence-free survival